Clinical staging and prognostic markers in chronic lymphocytic leukemia.
In this article we provide a brief review of the two staging systems in chronic lymphocytic leukemia, and we discuss the more recently identified, new prognostic markers that are of interest to clinicians and researchers in this field.
Long Island Jewish Medical Center, Division of Hematology-Oncology, 270-05 76th Avenue, New Hyde Park, NY 11040, USA. rai@lij.edu
Kanti R
KR
Rai
Tarun
T
Wasil
Uzma
U
Iqbal
Nancy
N
Driscoll
Dilip
D
Patel
Dale
D
Janson
Bhoomi
B
Mehrotra
D014408:Biomarkers, Tumor / Q000032:analysis; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood / Q000473:pathology* / Q000628:therapy; D008099:Liver / Q000473:pathology; D018655:Lymphocyte Count; D008297:Male; D009367:Neoplasm Staging; D011379:Prognosis; D013154:Spleen / Q000473:pathology
D014408:Biomarkers, Tumor